DailyIQ
Last updated 3 minutes ago

KDP·Keurig Dr Pepper Inc.

$.
-. (-.%)
After Hours
High
$30.68
Open
$30.33
Market Cap
41.42B
52W High
$35.94
Low
$30.16
P. Close
$30.21
P/E
22.61
52W Low
$24.88
Fwd P/E
56.71
DailyIQ Est.
$35.86
Technical Score (1D)
50
NEUTRAL
News Sentiment
67
BULLISH
The American Heart Association released a study today confirming that moderate caffeine consumption up to 400 mg per day is safe and may lower cardiovascular risk. This finding directly supports increased coffee consumption, which could translate into higher sales for Keurig Dr Pepper and other coffee retailers. The study also cautions against higher caffeine doses, potentially dampening demand for energy drinks and creating a relative advantage for coffee brands. For KDP, the implication is that consumer sentiment toward coffee may strengthen, potentially boosting revenue in the near term. Over the next 1–10 trading days, investors should monitor KDP’s sales data releases for any uptick in beverage volumes. Additionally, watch for any shifts in the energy drink sector, as a decline in that segment could further lift KDP’s market share. Analysts will likely adjust KDP’s earnings guidance if the study’s impact materializes in sales figures. Keep an eye on the company’s quarterly earnings call for commentary on how the health study influences marketing and pricing strategies. Finally, broader market sentiment toward health‑related consumer goods could affect KDP’s valuation, so monitor any related macroeconomic news.
Earnings Summary
Keurig Dr Pepper Inc. is a leading beverage and single‑serve brewing company with a diverse portfolio of well‑known brands sold in the U.S. and abroad, operating through U.S. Refreshment Beverages, U.S. Coffee, and International divisions, and positioning itself as a key player in the consumer‑defensive non‑alcoholic beverage sector. In the most recent two quarters, Q4 2025 and Q1 2026, the company reported EPS of $0.60 and $0.39, both beating estimates of $0.4259 and $0.3759, while revenue fell from $4.499 billion in Q4 2025 to $3.976 billion in Q1 2026, marking a decline after a prior growth phase where Q2 2025 and Q3 2025 revenue rose from $4.163 billion to $4.306 billion; EPS beats were maintained across all quarters, underscoring consistent profitability. Historically, KDP has shown a pattern of EPS beats in every reported quarter, with revenue growth in 2025 but a reversal in 2026, and the company has maintained a modest dividend yield of 2.83 % while announcing a 13th special dividend, reflecting cash‑flow confidence. Recent analyst activity has seen UBS, Citigroup, Barclays, Wells Fargo, and Sanford C. Bernstein lift price targets to the $36–$39 range and upgraded ratings to Buy or Overweight, while the company’s planned split into a Beverage Co. and a Global Coffee Co. in early 2027 and a leadership reshuffle signal a strategic realignment that could unlock value; the ex‑dividend date of June 26 adds a short‑term income focus. Investors should watch for the Q2 2026 earnings release on August 6, paying close attention to revenue and margin guidance, the timeline and regulatory approval of the split, and any updates on the company’s dividend policy, as these factors will shape the near‑term valuation and earnings outlook.

EPS

EstBeatMiss
$0.34$0.42$0.49$0.56$0.63Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$0.54 - -
Q1'26$0.38$0.39+3.8%
Q4'25$0.43$0.60+40.9%
Q3'25$0.54$0.54+0.4%
Q2'25$0.49$0.49+1.0%
Q1'25$0.38$0.42+9.8%

Revenue

EstBeatMiss
$3.1B$4.3B$5.5B$6.7B$7.9BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$7.3B - -
Q1'26$3.9B$4.0B+2.5%
Q4'25$3.8B$4.5B+17.5%
Q3'25 - $4.3B -
Q2'25 - $4.2B -
Q1'25 - $3.6B -

Market Data

KDP Stock Snapshot

KDP is currently trading at $30.21, giving Keurig Dr Pepper Inc. a market cap of 41.42B and a P/E ratio of 22.6. Today's range spans $30.16–$30.68, with shares opening at $30.33 and moving up $0.00 (0.0%) from the prior close. DailyIQ's technical score sits at 50/100 (HOLD) with a news sentiment reading of 67/100.

Over the past year KDP has traded between $24.88 and $35.94 - the current price is +21.4% off the 52-week low and -15.9% from the high. 25 analysts cover the stock with a Buy consensus and a mean 12-month target of $34.94 (range $28.00–$42.00), implying upside of +15.7%.

The setup for Keurig Dr Pepper Inc. (KDP) is neither bullish nor bearish - it's patient. Score: 50/100 (HOLD). Sentiment: bullish (67/100). Price: $30.21 (in the middle of its 52-week range in $24.88–$35.94). The current P/E ratio stands at 22.6. A large-cap with 41.42B in Consumer Defensive market cap in a neutral technical phase is exactly where position-sizing decisions get made before the next trend emerges.

The 52-week range of $24.88–$35.94 for KDP provides the structural reference that options traders, systematic funds, and discretionary managers all anchor to — and at $30.21 (in the middle of its 52-week range), the stock sits in a zone where the next 5–10% move will likely define which crowd was right. A HOLD signal at 50/100 and bullish news backdrop (67/100) don't break the tie yet, but they narrow the probability distribution toward the upside.